The effect of nephrectomy on Klotho, FGF-23 and bone metabolism

被引:9
|
作者
Kakareko, Katarzyna [1 ]
Rydzewska-Rosolowska, Alicja [1 ]
Brzosko, Szymon [1 ]
Gozdzikiewicz-Lapinska, Joanna [2 ]
Koc-Zorawska, Ewa [2 ]
Samocik, Pawel [3 ]
Kozlowski, Robert [3 ]
Mysliwiec, Michal [1 ]
Naumnik, Beata [1 ]
Hryszko, Tomasz [1 ]
机构
[1] Med Univ Bialystok, Dept Nephrol & Transplantat 1, Dialysis Unit, Ul Zurawia 14, PL-15540 Bialystok, Poland
[2] Med Univ Bialystok, Dept Hypertens & Nephrol 1, Dialysis Unit, Bialystok, Poland
[3] J Sniadecki Prov Hosp, Dept Oncol & Gen Urol, Bialystok, Poland
关键词
Acute GFR decline; Nephrectomy; Klotho; FGF-23; Bone metabolism; GROWTH-FACTOR; 23; ACUTE KIDNEY INJURY; MINERAL METABOLISM; CARDIAC-SURGERY; SERUM-LEVELS; PHOSPHATE; DISEASE; FGF23; CKD; FACTOR-23;
D O I
10.1007/s11255-017-1519-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Increased concentration of fibroblast growth factor 23 (FGF-23) and decreased levels of soluble Klotho (sKL) are linked to negative clinical outcomes among patients with chronic kidney disease and acute kidney injury. Therefore, it is reasonable to hypothesize that GFR reduction caused by nephrectomy might alter mineral metabolism and induces adverse consequences. Whether nephrectomy due to urological indications causes derangements in FGF-23 and sKL has not been studied. The aim of the study was to evaluate the effect of acute GFR decline due to unilateral nephrectomy on bone metabolism, FGF-23 and sKL levels. Methods This is a prospective, single-centre observational study of patients undergoing nephrectomy due to urological indications. Levels of C-terminal FGF-23 (c-FGF-23), sKL and bone turnover markers [beta-crosslaps (CTX), bone-specific alkaline phosphatase (bALP) and tartrate-resistant acid phosphatase 5b (TRAP 5b)] were measured before and after surgery (5 +/- 2 days). Results Twenty-nine patients were studied (14 females, age 63.0 +/- 11.6, eGFR 87.3 +/- 19.2 ml/min/1.73 m(2)). After surgery, eGFR significantly declined (p < 0.0001). Nephrectomy significantly decreased sKL level [709.8 (599.9-831.2) vs. 583.0 (411.7-752.6) pg/ml, p < 0.001] and did not change c-FGF-23 concentration [70.5 (49.8-103.3) vs. 77.1 (60.5-109.1) RU/ml, p = 0.9]. Simultaneously, alterations in bone turnover markers were observed. Serum concentration of CTX increased [0.49 (0.4-0.64) vs. 0.59 (0.46-0.85) ng/ml, p = 0.001], while bALP and TRAP 5b decreased [23.6 (18.8-31.4) vs. 17.9 (15.0-22.0) U/l, p < 0.0001 and 3.3 (3.0-3.7) vs. 2.8 (2.3-3.2) U/l, p < 0.001, respectively]. Conclusions Nephrectomy among patients with preserved renal function before surgery does not increase c-FGF-23 but reduces sKL. Moreover, nephrectomy results in derangements in bone turnover markers in short-term follow-up. These changes may participate in pathogenesis of bone disease after nephrectomy.
引用
收藏
页码:681 / 688
页数:8
相关论文
共 50 条
  • [41] Melorheostosis and FGF-23: Is there a relationship?
    Kerkeni, Samar
    Chapurlat, Roland
    JOINT BONE SPINE, 2008, 75 (04) : 486 - 488
  • [42] Cardiovascular remodeling as a result of fibroblast growth factor-23 (FGF-23)/Klotho imbalance in patients with CKD
    Ludmila Yu. Milovanova
    Marina V. Taranova
    Svetlana Yu. Milovanova
    Lidia V. Kozlovskaya (Lysenko)
    Anastasia I. Pasechnik
    Vasiliy V. Kozlov
    Vladimir D. Beketov
    Alexey V. Volkov
    Mikhail Ratanov
    International Urology and Nephrology, 2022, 54 : 1613 - 1621
  • [43] Cardiovascular remodeling as a result of fibroblast growth factor-23 (FGF-23)/Klotho imbalance in patients with CKD
    Milovanova, Ludmila Yu
    Taranova, Marina, V
    Milovanova, Svetlana Yu
    Kozlovskaya , Lidia, V
    Pasechnik, Anastasia, I
    Kozlov, Vasiliy V.
    Beketov, Vladimir D.
    Volkov, Alexey V.
    Ratanov, Mikhail
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (07) : 1613 - 1621
  • [44] New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients
    Memmos, Evangelos
    Papagianni, Aikaterini
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (01) : 55 - 62
  • [45] FGF23 and Klotho
    Kuro-o, Makoto
    ENDOCRINE JOURNAL, 2010, 57 : S243 - S243
  • [46] Zinc Supplementation Trial in Pediatric Chronic Kidney Disease: Effects on Circulating FGF-23 and Klotho
    Belostotsky, V.
    Atkinson, S. A.
    Filler, G.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2024, 11
  • [47] THE ROLE OF PHOSPHORUS, PTH, FGF-23, KLOTHO AND VITAMIN D ON HEMOGLOBIN LEVELS OF PATIENTS WITH CKD
    Russo, Luigi
    Battaglia, Yuri
    Bruzzese, Dario
    Di Iorio, Biagio
    Di Lullo, Luca
    Minutolo, Roberto
    Morrone, Luigi
    Russo, Domenico
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 199 - 199
  • [48] VARIABILITY OF KLOTHO AND FGF-23 LEVELS AFTER KIDNEY TRANSPLANTATION DEPENDING ON THE GLOMERULAR FILTRATION RATE
    Vazquez, Teresa
    Del Pozo Alvarez, Rafael
    Dolores Sanchez-Nino, Maria
    Caballero, Abelardo
    Leon, Myriam
    Ortiz, Alberto
    Porrini, Esteban
    Ruiz-Esteban, Pedro
    Lopez, Veronica
    Hernandez, Domingo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I741 - I742
  • [49] PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond
    Portales-Castillo, Ignacio
    Simic, Petra
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [50] Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism
    L. Darryl Quarles
    Nature Reviews Endocrinology, 2012, 8 : 276 - 286